Extracorporeal shock wave lithotripsy — non-invasive stone fragmentation by focused acoustic pulses generated outside the body
Before any shock is fired, the treating team must confirm the stone is a good ESWL candidate. Non-contrast CT of the kidneys, ureters and bladder (CT-KUB) is now the diagnostic gold standard, providing precise stone size, density and its distance from the skin surface — three variables that, taken together, predict fragmentation success better than any single measurement.
Non-contrast helical CT (CT-KUB) has replaced intravenous urography as the first-line study for suspected renal colic: it detects essentially all radiopaque and radiolucent stones except pure matrix or indinavir stones, with sensitivity 95–98% and specificity around 96–98%.
Beyond simple detection, CT provides three quantitative predictors used to select ESWL candidates:
• Stone size (maximal diameter on axial slices) — the single strongest predictor of stone-free rate • Mean stone density in Hounsfield units (HU) — a surrogate for stone hardness/crystal microstructure • Skin-to-stone distance (SSD) — the depth the shock wave must travel while losing energy to intervening tissue
During the actual procedure, real-time targeting uses biplanar fluoroscopy (for radiopaque stones) or integrated ultrasound (for radiolucent stones and to avoid ionizing radiation, especially in pregnancy and pediatrics).
A landmark predictive nomogram (Patel et al.) combining stone size, HU density and SSD >10cm can pre-operatively identify roughly 90% of patients who will fail ESWL — allowing those patients to be triaged directly to ureteroscopy or percutaneous nephrolithotomy instead.
ESWL performs best for renal stones under 10mm and reasonably well up to 20mm; above 20mm, stone-free rates fall sharply and PCNL is generally preferred. Lower-pole calyceal stones fragment normally but clear poorly against gravity, reducing effective success even when fragmentation itself is adequate.
Stone composition — inferred from HU density and sometimes dual-energy CT — matters enormously:
• Uric acid and struvite stones: soft, low density (<500 HU), fragment easily • Calcium oxalate dihydrate (weddellite): moderate density, fragments reasonably well • Calcium oxalate monohydrate (whewellite) and brushite: dense, crystalline, fragmentation-resistant • Cystine stones: hardest, often barely radiopaque, poor ESWL candidates
Dual-energy CT can non-invasively distinguish uric acid from calcium-containing stones, which changes both the treatment plan and whether medical dissolution therapy is an option instead of lithotripsy.
Absolute contraindications to ESWL include pregnancy, uncorrected bleeding diathesis, and untreated urinary tract infection or urosepsis (fragmenting an infected stone can seed bacteremia). Uncontrolled hypertension and large abdominal aortic aneurysm near the treatment path are relative contraindications.
Pre-procedural checklist:
1. Confirm stone burden and location on recent imaging (CT within weeks) 2. Rule out active infection — sterile urine culture required 3. Review anticoagulation — antiplatelet/anticoagulant agents held per protocol (bleeding risk) 4. Assess for distal obstruction that would trap fragments (consider pre-stenting) 5. Position patient (prone or supine depending on stone location and lithotripter model) and confirm coupling path is unobstructed by bowel gas or bone
A lithotripter must first create a short, high-amplitude acoustic pulse, then deliver essentially all of that energy across the skin into soft tissue without loss. Three fundamentally different generator technologies accomplish the first task; a degassed water cushion or coupling gel accomplishes the second — and coupling quality alone can make or break a treatment session.
Electrohydraulic (spark-gap) generators — the original Dornier HM3 technology — discharge a high-voltage spark underwater at one focus of a metal ellipsoid reflector. The spark vaporizes a small volume of fluid, generating a spherical shock wave that the reflector redirects toward the second focal point. Output per pulse is high and the focal zone is relatively large, but electrodes wear out and require periodic replacement.
Electromagnetic generators use a flat or cylindrical coil beneath a metal membrane; a high-current pulse through the coil launches the membrane, generating a planar acoustic wave that is then focused by an acoustic lens or a parabolic reflector. Output is highly reproducible shock-to-shock and the electronics are durable, making this the most common design in modern clinical lithotripters.
Piezoelectric generators fire thousands of piezoceramic elements arranged over a spherical dish simultaneously; because the elements themselves are arranged on a sphere, the wave is inherently self-focusing to a small, precise focal volume. Pain at the skin is lowest with this design because the entrance-surface energy density is spread across a large array.
Acoustic impedance mismatch is the enemy of shock wave therapy. Air has an acoustic impedance roughly four orders of magnitude lower than soft tissue; even a sub-millimeter air gap between the treatment head and skin reflects the great majority of incident energy back out, delivering it nowhere useful.
Modern lithotripters use a degassed water cushion pressed directly against the skin, or a coupling gel applied without air bubbles. Studies quantifying the effect of imperfect coupling report up to 30% energy loss with even modest bubble coverage of the coupling interface — one of the most common, and most preventable, causes of a disappointing fragmentation session.
Before treatment begins, the technologist visually inspects the coupling interface (often via a camera built into the treatment head) and re-applies gel or repositions the cushion until no air pockets are visible.
Randomized comparisons show that meticulous, bubble-free coupling alone can improve stone-free rates by a clinically meaningful margin — coupling quality is one of the few fully operator-controllable variables in the entire procedure.
Shock rate (pulses per minute) affects both fragmentation efficiency and tissue injury. Comparative trials found that slower shock delivery — roughly 60 shocks/min (≈1 Hz) — produces better stone-free rates and less renal trauma than the historically common 120/min, because cavitation bubbles from the previous pulse have time to fully collapse and the parenchymal vasoconstrictive protective reflex has time to engage.
Most protocols also "ramp" energy: treatment starts at low voltage (e.g., 12–14 kV) for the first 100–500 shocks, then steps up toward the target voltage (often 18–24 kV). This pre-conditioning induces renal vasoconstriction that measurably reduces hemorrhagic injury compared with starting at full power immediately, without compromising fragmentation.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
The defining trick of lithotripsy is geometric: an ellipsoid reflector has the mathematical property that every ray leaving one focus (F1) reflects to pass through the second focus (F2). By placing the shock source at F1 and the stone at F2, thousands of individually harmless pressure waves are superimposed into a single intense pulse concentrated on a target the width of a pencil eraser.
An ellipse is defined by two foci such that the sum of distances from any point on the curve to both foci is constant. Reflected acoustically, this means every wavefront generated at F1 and bounced off the ellipsoid shell arrives at F2 having traveled the same total path length — so all the individually reflected wavelets arrive in phase and sum constructively into one sharp, high-amplitude pulse.
This is why the stone must be placed precisely at F2 using fluoroscopic or ultrasound targeting before treatment: even a few millimeters of mis-registration moves the target out of the narrow high-energy focal volume, wasting shocks on surrounding renal parenchyma instead of the stone.
Unlike a continuous ultrasound beam, a lithotripsy shock wave is a single transient event with a very specific waveform:
• Rise time: the pressure climbs from baseline to peak positive pressure in under 100 nanoseconds — one of the fastest pressure transients used therapeutically in medicine • Compressive (positive) phase: peak pressure of roughly 30–110 MPa (300–1,100 bar) depending on generator type and voltage, lasting ~1 microsecond • Tensile (negative) phase: pressure swings below ambient to roughly −5 to −12 MPa for several microseconds as the compressive wavefront passes
This biphasic compressive-then-tensile shape is what drives two distinct fragmentation mechanisms simultaneously (direct compressive fracture and cavitation from the tensile phase) — a plain continuous ultrasound wave could not do this.
The focal zone at −6dB (the region receiving at least half the peak energy) is typically only 4–8mm wide laterally but 20–50mm long axially — an intentionally elongated "cigar" shape that provides some tolerance for respiratory motion of the kidney without spreading energy over healthy parenchyma laterally.
When the compressive wavefront reaches the stone, the mismatch in acoustic impedance between the stone (dense, ~2.0–2.8 g/cm³) and surrounding urine/tissue causes part of the wave to transmit through the stone and part to reflect. The transmitted compressive stress front propagates through the stone at its internal sound speed (~4,000 m/s for calcium oxalate), briefly compressing the crystal lattice.
This single pulse rarely fractures a stone outright. Fragmentation is fundamentally a fatigue phenomenon: the accumulated effect of hundreds to thousands of sub-fracture-threshold pulses gradually propagating microcracks — which is why treatment requires so many shocks rather than a few very powerful ones.
No single mechanism explains how a shock wave breaks a stone. Four distinct physical processes act simultaneously and reinforce each other over the course of a treatment session, converting a single 8mm calculus into hundreds of sand-like fragments capable of passing through a ureter roughly the width of a strand of spaghetti.
When the compressive wavefront reaches the far (distal) surface of the stone — the boundary between dense stone and much softer urine — it reflects as a tensile wave traveling back into the stone. Because stone material is far weaker in tension than in compression, this reflected tensile wave, known as the Hopkinson (spallation) effect, tends to pull off thin flakes from the back surface of the stone even when the front surface shows no visible damage.
This is why fragmentation often begins on the side of the stone facing away from the shock source — a counterintuitive but well-documented pattern confirmed by high-speed imaging of stones treated in vitro.
The tensile phase of the shock wave also nucleates cavitation bubbles in the urine surrounding the stone. These microbubbles expand during the low-pressure tensile phase, then violently collapse (implode) within microseconds as pressure normalizes.
Asymmetric bubble collapse near a solid surface generates a high-velocity microjet — estimated at up to 100–150 m/s in some models — that impacts the stone surface with very high localized pressure, eroding material much like sandblasting. Collapsing bubbles also emit their own secondary shock waves, compounding the mechanical stress on the stone surface. Cavitation is thought to be the dominant mechanism for stones with irregular or heterogeneous internal structure.
Dynamic fatigue describes the cumulative effect of thousands of sub-threshold stress cycles: each individual pulse may fall below the stone's fracture strength, but repeated loading propagates microscopic cracks that were seeded by earlier pulses, exactly as metal fatigue eventually snaps a paperclip bent back and forth. Stone hardness — expressed clinically through HU density and mineral composition — determines how many cycles are needed.
Quasi-static squeezing refers to the brief but real compression of the whole stone as the wavefront transits it: because the stone's acoustic impedance differs at its irregular internal boundaries (inclusions, layered growth rings typical of calcium oxalate monohydrate stones), internal shear stresses concentrate exactly at these boundaries, which is why layered or heterogeneous stones often fragment along their natural growth planes.
Composition determines difficulty: uric acid and struvite stones typically fragment within a few hundred shocks; calcium oxalate dihydrate needs roughly 1,000–2,000; dense calcium oxalate monohydrate and brushite often need the full 2,000–3,000 shock allotment; cystine stones are frequently ESWL-resistant altogether.
Because fragmentation is a fatigue process, spreading a fixed number of shocks over a slower rate (60–90/min) rather than delivering them rapidly measurably improves final fragment yield — the mechanism needs time between pulses for cavitation bubbles to fully collapse before the next wavefront arrives.
Fragmenting the stone is only half the job — the resulting gravel must still traverse three natural narrowings of the ureter (the ureteropelvic junction, where it crosses the iliac vessels, and the ureterovesical junction) before reaching the bladder. Outcome is measured not by fragmentation itself but by the stone-free rate on follow-up imaging, typically at 3 months.
Fragments ≤4mm generally pass spontaneously, though ≤2mm is a more comfortable and reliable threshold; fragments approaching 5–7mm may require weeks and can still obstruct at a narrow point. Ureteral peristalsis drives passage, aided clinically by medical expulsive therapy — alpha-blockers (tamsulosin) that relax ureteral smooth muscle, shown in meta-analyses to increase passage rates and reduce time-to-passage for fragments up to about 10mm.
Lower pole renal fragments face a unique problem: even when perfectly pulverized, gravity does not favor drainage from the dependent lower calyx into the ureteropelvic junction, and studies (the Lower Pole I trial) have shown ESWL stone-free rates for lower-pole stones roughly 10–20 percentage points below otherwise equivalent stones in other calyces.
When a large fragment burden descends together and outpaces the ureter's ability to clear it, fragments can stack into a column obstructing the ureteral lumen — a "steinstrasse" or stone street, occurring in roughly 4–7% of treatments and correlating strongly with larger pre-treatment stone volume.
Management is stratified by symptoms: an asymptomatic steinstrasse with preserved renal function may be observed or treated with expulsive therapy; a symptomatic or obstructing steinstrasse typically requires ureteroscopy to clear the leading fragment, or occasionally a second localized ESWL treatment aimed at the column itself.
ESWL is remarkably safe relative to its efficacy: transient gross or microscopic hematuria is nearly universal and expected. Clinically significant perirenal or subcapsular hematoma requiring intervention occurs in roughly 1–4% of sessions, though subclinical hematomas are detectable by imaging in up to ~12% depending on protocol and patient factors (anticoagulation, hypertension, larger kidney size increase risk).
Renal function impact is generally minimal in a single treatment but repeated aggressive treatment of the same kidney has been associated with small reductions in differential renal function and, controversially, some studies have suggested a modest long-term association between multiple ESWL sessions and hypertension — an area of ongoing research.
Compared to alternative first-line treatments, ESWL remains attractive because it requires no anesthesia incision, can often be done as an outpatient procedure in under an hour, and avoids the instrumentation-related risks of ureteroscopy — but for stones >20mm, dense/hard composition, or lower-pole location, primary ureteroscopy or PCNL now frequently outperform it in stone-free rate per single procedure.